(COR) Cencora - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03073E1055
COR: Pharmaceuticals, Vaccines, Healthcare, Equipment, Supplies, Software
Cencora, Inc. (NYSE: COR) operates as a global healthcare solutions provider, specializing in the sourcing and distribution of pharmaceutical products. The company serves a diverse range of customers, including acute care hospitals, retail pharmacies, and biotechnology manufacturers. Its U.S. Healthcare Solutions segment offers a comprehensive suite of services, including pharmaceutical distribution, pharmacy management, supply chain software, and clinical trial support. The segment also provides specialty products, such as injectable pharmaceuticals and vaccines, to healthcare providers. Additionally, Cencora serves the animal health market with products like vaccines and parasiticides, and offers data analytics and consulting services to pharmaceutical manufacturers.
The company’s International Healthcare Solutions segment focuses on global pharmaceutical wholesale and commercialization services. It distributes healthcare products to international markets, including pharmacies, hospitals, and health centers. The segment also provides specialty logistics services for the biopharmaceutical industry. Cencora, formerly known as AmerisourceBergen Corporation, has a long history dating back to 1871. Headquartered in Conshohocken, Pennsylvania, the company rebranded as Cencora, Inc. in August 2023, reflecting its strategic evolution in the healthcare sector.
3-Month Forecast: Based on
Additional Sources for COR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
COR Stock Overview
Market Cap in USD | 56,587m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC Sub-Industry | Health Care Distributors |
IPO / Inception | 1995-04-04 |
COR Stock Ratings
Growth Rating | 90.8 |
Fundamental | 59.1 |
Dividend Rating | 53.0 |
Rel. Strength | 33.2 |
Analysts | 4.06/5 |
Fair Price Momentum | 331.94 USD |
Fair Price DCF | 331.97 USD |
COR Dividends
Dividend Yield 12m | 0.62% |
Yield on Cost 5y | 1.89% |
Annual Growth 5y | 4.12% |
Payout Consistency | 99.6% |
COR Growth Ratios
Growth Correlation 3m | 96.6% |
Growth Correlation 12m | 79.5% |
Growth Correlation 5y | 98.3% |
CAGR 5y | 27.21% |
CAGR/Max DD 5y | 1.53 |
Sharpe Ratio 12m | 0.67 |
Alpha | 22.96 |
Beta | 0.093 |
Volatility | 21.51% |
Current Volume | 4122.8k |
Average Volume 20d | 1563.4k |
As of May 09, 2025, the stock is trading at USD 283.77 with a total of 4,122,766 shares traded.
Over the past week, the price has changed by -2.29%, over one month by +3.29%, over three months by +15.44% and over the past year by +27.76%.
Partly, yes. Based on ValueRay Fundamental Analyses, Cencora (NYSE:COR) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 59.11 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COR as of May 2025 is 331.94. This means that COR is currently undervalued and has a potential upside of +16.98% (Margin of Safety).
Cencora has received a consensus analysts rating of 4.06. Therefor, it is recommend to buy COR.
- Strong Buy: 9
- Buy: 1
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, COR Cencora will be worth about 358.5 in May 2026. The stock is currently trading at 283.77. This means that the stock has a potential upside of +26.33%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 297.5 | 4.8% |
Analysts Target Price | 295 | 4% |
ValueRay Target Price | 358.5 | 26.3% |